General Mills is selling its European Yoplait business in exchange for full control of the same brand in Canada, a move that concentrates the company’s yogurt enterprise in North America. The company said Tuesday it will sell its 51% controlling interest in …
See Original Article

EAST GREENBUSH – The “antibody cocktail” being developed by Regeneron Pharmaceuticals has proven highly effective in reducing and shortening COVID-19 symptoms, according to test results announced by the company this week. The cocktail worked …
See Original Article

A radioligand acquired as part of a $2.1bn deal – and which the sellside believes to be Novartis’s most valuable R&D asset – hits in phase II. Trial Results. Novartis HQ. Success in the Vision trial means that Novartis is another step closer to having a second …
See Original Article

Janet Yellen, the current Treasury secretary, and Jerome Powell, who succeeded Yellen as Federal Reserve chair during the Trump administration, each stressed in prepared remarks that the economic pain caused by the Covid-19 pandemic would have been …
See Original Article

NEW DELHI: Cadila Healthcare on Wednesday said the company and its subsidiary Zydus Pharmaceuticals (USA) Inc have reached a settlement with US-based firm Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb, over patents for …
See Original Article